EP
CBIO icon

Essential Partners’s Crescent Biopharma CBIO Stock Holding History

Essential Partners’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$44 Buy
+3
New +$50 ﹤0.01% 2777

Other funds holding CBIO

Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners's CBIO Position: Q3 2026 in Review

Essential Partners opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 3 shares worth $44. The stake represents ﹤0.01% of the portfolio and ranks #2777 among its holdings.

5 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • Essential Partners held 3 shares of Crescent Biopharma worth $44 as of Q3 2026.
  • Crescent Biopharma was a new Essential Partners position in Q3 2026.
  • Crescent Biopharma made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2777 holding.
  • 5 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.